Korro Bio is a biotechnology company focused on developing novel gene editing technologies to advance precision medicine and transform the treatment of genetic diseases. Founded in 2018, Korro Bio's innovative approaches have the potential to revolutionize the field of genetic medicine and bring about new therapeutic solutions for patients worldwide.

Director, Toxicology

Director, Analytical Development - Oligonucleotide

Associate Director of Manufacturing Sciences

Associate Scientist, Disease Area Biology

Senior Director, Clinical Development

Associate Director/Director, Quality Assurance

SEC Reporting Manager

Senior Manager, Strategy and Portfolio Planning

RNA Therapeutics Scientist

<div><b>Company Summary:</b>&nbsp;<span style="font-size: 11pt">Korro is a biopharmaceutical company focused on developing a new class of genetic medicines for both rare and highly prevalent diseases using its proprietary RNA editing platform. Korro is generating a portfolio of differentiated programs that are designed to harness the body’s natural RNA editing process to effect a precise yet transient single base edit. By editing RNA instead of DNA, Korro is expanding the reach of genetic medicines by delivering additional precision and tunability, which has the potential for increased specificity and improved long-term tolerability. Using an oligonucleotide-based approach, Korro expects to bring its medicines to patients by leveraging its proprietary platform with precedented delivery modalities, manufacturing know-how, and established regulatory pathways of approved oligonucleotide drugs. Korro’s lead program is Alpha-1 Antitrypsin Deficiency (AATD). Korro is based in Cambridge, Massachusetts. </span></div><div><br></div><div><span style="font-size: 11pt">We are collaborative and united by a common mission. We are building a company with extraordinary people with an audacious vision to create transformative genetic medicines for prevalent diseases. Our values - </span><i style="font-size: 11pt">Rewrite the future, On the Cutting Edge, Better Together, Dynamically Different, Kindness and Integrity </i><span style="font-size: 11pt">form the fabric of the organization. They are reinforced daily and serve as key dimensions in the hiring process to help us ensure that Korro is a magnet for outstanding talent and a great place to work. Join us as we redefine what's possible in genetic medicine and work to make a lasting impact on human health.</span></div><div><br></div><div><span style="font-size: 10pt;">Position Summary: Korro Bio&nbsp;is&nbsp;seeking an analytical scientist to join the growing CMC team. You will focus on management of CMO analytical labs as well as development of analytical methods, characterization of impurities, degradation pathways, and transfer, qualification/validation of analytical methods for RNA-based therapies. This role will support and manage - the quality and stability of drug substances and drug products throughout the development lifecycle. You will work closely with cross-functional teams and external partners to ensure that analytical data supports regulatory filings and clinical trial progression.</span></div>

Senior Scientist, Analytical Sciences

<div><b>Company Summary:</b>&nbsp;<span style="font-size: 11pt">Korro is a biopharmaceutical company focused on developing a new class of genetic medicines for both rare and highly prevalent diseases using its proprietary RNA editing platform. Korro is generating a portfolio of differentiated programs that are designed to harness the body’s natural RNA editing process to effect a precise yet transient single base edit. By editing RNA instead of DNA, Korro is expanding the reach of genetic medicines by delivering additional precision and tunability, which has the potential for increased specificity and improved long-term tolerability. Using an oligonucleotide-based approach, Korro expects to bring its medicines to patients by leveraging its proprietary platform with precedented delivery modalities, manufacturing know-how, and established regulatory pathways of approved oligonucleotide drugs. Korro’s lead program is Alpha-1 Antitrypsin Deficiency (AATD). Korro is based in Cambridge, Massachusetts. </span></div><div><br></div><div><span style="font-size: 11pt">We are collaborative and united by a common mission. We are building a company with extraordinary people with an audacious vision to create transformative genetic medicines for prevalent diseases. Our values - </span><i style="font-size: 11pt">Rewrite the future, On the Cutting Edge, Better Together, Dynamically Different, Kindness and Integrity </i><span style="font-size: 11pt">form the fabric of the organization. They are reinforced daily and serve as key dimensions in the hiring process to help us ensure that Korro is a magnet for outstanding talent and a great place to work. Join us as we redefine what's possible in genetic medicine and work to make a lasting impact on human health.</span></div>

Director, Clinical Assay Development & Biomarkers

<div><b>Company Summary:</b>&nbsp;<span style="font-size: 11pt">Korro is a biopharmaceutical company focused on developing a new class of genetic medicines for both rare and highly prevalent diseases using its proprietary RNA editing platform. Korro is generating a portfolio of differentiated programs that are designed to harness the body’s natural RNA editing process to effect a precise yet transient single base edit. By editing RNA instead of DNA, Korro is expanding the reach of genetic medicines by delivering additional precision and tunability, which has the potential for increased specificity and improved long-term tolerability. Using an oligonucleotide-based approach, Korro expects to bring its medicines to patients by leveraging its proprietary platform with precedented delivery modalities, manufacturing know-how, and established regulatory pathways of approved oligonucleotide drugs. Korro’s lead program is Alpha-1 Antitrypsin Deficiency (AATD). Korro is based in Cambridge, Massachusetts. </span></div><div><br></div><div><span style="font-size: 11pt">We are collaborative and united by a common mission. We are building a company with extraordinary people with an audacious vision to create transformative genetic medicines for prevalent diseases. Our values - </span><i style="font-size: 11pt">Rewrite the future, On the Cutting Edge, Better Together, Dynamically Different, Kindness and Integrity </i><span style="font-size: 11pt">form the fabric of the organization. They are reinforced daily and serve as key dimensions in the hiring process to help us ensure that Korro is a magnet for outstanding talent and a great place to work. Join us as we redefine what's possible in genetic medicine and work to make a lasting impact on human health.</span></div><div><br></div><div><b style="font-size: 11pt;">Position Summary:</b></div><div><span style="font-size: 10pt;">We are seeking an experienced and strategic </span><b style="font-size: 10pt;">Senior Scientist, Machine Learning</b><span style="font-size: 10pt;"> to drive the development and application of machine learning solutions for genetic medicine discovery and development. This role offers the opportunity to apply deep learning and statistical methods in current and novel areas across our RNA editing platform, from target identification and oligonucleotide design to patient stratification and clinical optimization.</span></div><div><span style="font-size: 10pt;">&nbsp;</span></div><div><span style="font-size: 10pt;">The ideal candidate will bring deep expertise in both machine learning and statistics, enabling rigorous experimental design, hypothesis testing, and model validation in complex biological systems. You will have significant autonomy to identify and explore new applications of ML/AI across diverse functions within the organization, working at the intersection of computational biology, drug discovery, and precision medicine.</span></div><div><br></div><div><br></div><div><br></div>

Senior Scientist, Machine Learning (Drug Development)

<div><b>Company Summary:</b>&nbsp;<span style="font-size: 11pt">Korro is a biopharmaceutical company focused on developing a new class of genetic medicines for both rare and highly prevalent diseases using its proprietary RNA editing platform. Korro is generating a portfolio of differentiated programs that are designed to harness the body’s natural RNA editing process to effect a precise yet transient single base edit. By editing RNA instead of DNA, Korro is expanding the reach of genetic medicines by delivering additional precision and tunability, which has the potential for increased specificity and improved long-term tolerability. Using an oligonucleotide-based approach, Korro expects to bring its medicines to patients by leveraging its proprietary platform with precedented delivery modalities, manufacturing know-how, and established regulatory pathways of approved oligonucleotide drugs. Korro’s lead program is Alpha-1 Antitrypsin Deficiency (AATD). Korro is based in Cambridge, Massachusetts. </span></div><div><br></div><div><span style="font-size: 11pt">We are collaborative and united by a common mission. We are building a company with extraordinary people with an audacious vision to create transformative genetic medicines for prevalent diseases. Our values - </span><i style="font-size: 11pt">Rewrite the future, On the Cutting Edge, Better Together, Dynamically Different, Kindness and Integrity </i><span style="font-size: 11pt">form the fabric of the organization. They are reinforced daily and serve as key dimensions in the hiring process to help us ensure that Korro is a magnet for outstanding talent and a great place to work. Join us as we redefine what's possible in genetic medicine and work to make a lasting impact on human health.</span></div><div><br></div><div><b style="font-size: 16px;">Position Summary:</b></div><div><span style="font-size: 16px;">&nbsp;</span></div><div><span style="font-size: 16px;">We are seeking an experienced clinical development physician to lead one or more clinical programs at Korro. In this highly visible role reporting to the Chief Medical Officer, you will drive clinical development related activities for Korro’s lead program in Alpha-1 Antitrypsin Deficiency (AATD), as well as additional pipeline programs. This is an onsite role in Cambridge, Massachusetts, with a requirement to be in the office 3 days a week.</span></div><div><span style="font-size: 16px;">Excellent written and oral communication skills are required, as is the desire and ability to work in a small, fast-paced, and patient-focused environment.</span></div>

<div><b>Company Summary:</b>&nbsp;<span style="font-size: 11pt">Korro is a biopharmaceutical company focused on developing a new class of genetic medicines for both rare and highly prevalent diseases using its proprietary RNA editing platform. Korro is generating a portfolio of differentiated programs that are designed to harness the body’s natural RNA editing process to effect a precise yet transient single base edit. By editing RNA instead of DNA, Korro is expanding the reach of genetic medicines by delivering additional precision and tunability, which has the potential for increased specificity and improved long-term tolerability. Using an oligonucleotide-based approach, Korro expects to bring its medicines to patients by leveraging its proprietary platform with precedented delivery modalities, manufacturing know-how, and established regulatory pathways of approved oligonucleotide drugs. Korro’s lead program is Alpha-1 Antitrypsin Deficiency (AATD). Korro is based in Cambridge, Massachusetts. </span></div><div><br></div><div><span style="font-size: 11pt">We are collaborative and united by a common mission. We are building a company with extraordinary people with an audacious vision to create transformative genetic medicines for prevalent diseases. Our values - </span><i style="font-size: 11pt">Rewrite the future, On the Cutting Edge, Better Together, Dynamically Different, Kindness and Integrity </i><span style="font-size: 11pt">form the fabric of the organization. They are reinforced daily and serve as key dimensions in the hiring process to help us ensure that Korro is a magnet for outstanding talent and a great place to work. Join us as we redefine what's possible in genetic medicine and work to make a lasting impact on human health.</span></div><div><br></div><div><b>Position Summary:</b></div><div>Korro Bio&nbsp;is&nbsp;seeking a Director of Process Development to join the growing CMC (Chemistry, Manufacturing, and Controls) team. You will play a critical role in developing and optimizing manufacturing processes for our oligonucleotide-based Therapeutics. This role requires a deep understanding of process development, scale-up, and technology transfer for drug substance as well as cross-functional collaboration with internal and external partners. You will lead a team of scientists and engineers to ensure the scalability, efficiency, and regulatory compliance of our therapeutic development.</div>

Director, Process Development

<div><b>Company Summary:</b>&nbsp;<span style="font-size: 11pt">Korro is a biopharmaceutical company focused on developing a new class of genetic medicines for both rare and highly prevalent diseases using its proprietary RNA editing platform. Korro is generating a portfolio of differentiated programs that are designed to harness the body’s natural RNA editing process to effect a precise yet transient single base edit. By editing RNA instead of DNA, Korro is expanding the reach of genetic medicines by delivering additional precision and tunability, which has the potential for increased specificity and improved long-term tolerability. Using an oligonucleotide-based approach, Korro expects to bring its medicines to patients by leveraging its proprietary platform with precedented delivery modalities, manufacturing know-how, and established regulatory pathways of approved oligonucleotide drugs. Korro’s lead program is Alpha-1 Antitrypsin Deficiency (AATD). Korro is based in Cambridge, Massachusetts. </span></div><div><br></div><div><span style="font-size: 11pt">We are collaborative and united by a common mission. We are building a company with extraordinary people with an audacious vision to create transformative genetic medicines for prevalent diseases. Our values - </span><i style="font-size: 11pt">Rewrite the future, On the Cutting Edge, Better Together, Dynamically Different, Kindness and Integrity </i><span style="font-size: 11pt">form the fabric of the organization. They are reinforced daily and serve as key dimensions in the hiring process to help us ensure that Korro is a magnet for outstanding talent and a great place to work. Join us as we redefine what's possible in genetic medicine and work to make a lasting impact on human health.</span></div><div><br></div><div><b>Position Summary:</b></div><div>Korro Bio is seeking a highly motivated Senior Director of Toxicology to lead the design and execution of nonclinical safety studies across our RNA editing portfolio. Reporting to the VP of Research and Preclinical, this individual will be a key scientific and strategic contributor responsible for building and advancing Korro’s toxicology capabilities, with an emphasis on oligonucleotide-based therapeutics. The ideal candidate brings deep experience in nonclinical development, a collaborative mindset, and a passion for bringing novel genetic medicines to patients.</div>

Senior Director, Toxicology

<div><b>Company Summary:</b>&nbsp;<span style="font-size: 11pt">Korro is a biopharmaceutical company focused on developing a new class of genetic medicines for both rare and highly prevalent diseases using its proprietary RNA editing platform. Korro is generating a portfolio of differentiated programs that are designed to harness the body’s natural RNA editing process to effect a precise yet transient single base edit. By editing RNA instead of DNA, Korro is expanding the reach of genetic medicines by delivering additional precision and tunability, which has the potential for increased specificity and improved long-term tolerability. Using an oligonucleotide-based approach, Korro expects to bring its medicines to patients by leveraging its proprietary platform with precedented delivery modalities, manufacturing know-how, and established regulatory pathways of approved oligonucleotide drugs. Korro’s lead program is Alpha-1 Antitrypsin Deficiency (AATD). Korro is based in Cambridge, Massachusetts. </span></div><div><br></div><div><span style="font-size: 11pt">We are collaborative and united by a common mission. We are building a company with extraordinary people with an audacious vision to create transformative genetic medicines for prevalent diseases. Our values - </span><i style="font-size: 11pt">Rewrite the future, On the Cutting Edge, Better Together, Dynamically Different, Kindness and Integrity </i><span style="font-size: 11pt">form the fabric of the organization. They are reinforced daily and serve as key dimensions in the hiring process to help us ensure that Korro is a magnet for outstanding talent and a great place to work. Join us as we redefine what's possible in genetic medicine and work to make a lasting impact on human health.</span></div><div><br></div><div><span style="font-size: 12pt;">The Clinical Scientist will work closely with the clinical development department to provide support in one or more Clinical Project Teams at Korro Bio in order to ensure the successful design and implementation of Clinical Development Plans. This role serves to ensure the design of cost-efficient clinical trials to meet the needs of internal and external stakeholders.</span></div><div><br></div><div><span style="font-size: 12pt;"> S/he is responsible for effective scientific oversight of studies (in partnership with study / program medical director and clinical operation team members) and supports appropriate interpretation and communication of clinical trial data (including high quality regulatory submissions). Major areas of responsibility include contributing to clinical trial design/protocol writing and execution of Company-sponsored clinical trials at all phases of development, clinical trial data analysis, internal and external communication of project plans and progress, safety monitoring and mitigation, and key contributions to regulatory submissions, publications, and clinical data communications.</span></div>

Senior Manager, Clinical Scientist

<div><b>Company Summary:</b>&nbsp;<span style="font-size: 11pt">Korro is a biopharmaceutical company focused on developing a new class of genetic medicines for both rare and highly prevalent diseases using its proprietary RNA editing platform. Korro is generating a portfolio of differentiated programs that are designed to harness the body’s natural RNA editing process to effect a precise yet transient single base edit. By editing RNA instead of DNA, Korro is expanding the reach of genetic medicines by delivering additional precision and tunability, which has the potential for increased specificity and improved long-term tolerability. Using an oligonucleotide-based approach, Korro expects to bring its medicines to patients by leveraging its proprietary platform with precedented delivery modalities, manufacturing know-how, and established regulatory pathways of approved oligonucleotide drugs. Korro is based in Cambridge, Massachusetts. </span></div><div><br></div><div><span style="font-size: 11pt">We are collaborative and united by a common mission. We are building a company with extraordinary people with an audacious vision to create transformative genetic medicines for prevalent diseases. Our values - </span><i style="font-size: 11pt">Rewrite the future, On the Cutting Edge, Better Together, Dynamically Different, Kindness and Integrity </i><span style="font-size: 11pt">form the fabric of the organization. They are reinforced daily and serve as key dimensions in the hiring process to help us ensure that Korro is a magnet for outstanding talent and a great place to work. Join us as we redefine what's possible in genetic medicine and work to make a lasting impact on human health.</span></div><div><br></div><div><b>Position&nbsp;Summary:&nbsp;</b>Korro Bio&nbsp;is&nbsp;seeking a&nbsp;passionate, self-motivated, and talented leader with a background in oligonucleotide therapeutics to join our Analytical Development team within CMC function. In this key role, you will be leading for all aspects of analytical development related to both drug substance and drug product components of the modalities. The successful candidate will be responsible for the&nbsp;deployment&nbsp;of methods for routine analysis&nbsp;of&nbsp;oligonucleotides&nbsp;to advance our RNA editing drug discovery&nbsp;platform and&nbsp;programs.&nbsp;The successful candidate will play a key role in advancing a pipeline of products from the early stage drug development to market approval. Success will require leadership across a matrixed analytical organization, effective collaboration with other CMC functions, close management of CDMO activities, and significant contribution to the overall CMC strategy for the program. Deep knowledge of cGMPs and regulatory guidelines, significant experience in the CMC development of oligonucleotide and considerable expertise in the analytical techniques and strategies commonly used in the development of oligonucleotides is essential. Candidate must express a high attention to details, be comfortable multitasking in a fast-paced startup environment.&nbsp; &nbsp;</div>

Director, Analytical Development

<div><b>Company Summary:</b>&nbsp;<span style="font-size: 11pt">Korro is a biopharmaceutical company focused on developing a new class of genetic medicines for both rare and highly prevalent diseases using its proprietary RNA editing platform. Korro is generating a portfolio of differentiated programs that are designed to harness the body’s natural RNA editing process to effect a precise yet transient single base edit. By editing RNA instead of DNA, Korro is expanding the reach of genetic medicines by delivering additional precision and tunability, which has the potential for increased specificity and improved long-term tolerability. Using an oligonucleotide-based approach, Korro expects to bring its medicines to patients by leveraging its proprietary platform with precedented delivery modalities, manufacturing know-how, and established regulatory pathways of approved oligonucleotide drugs. Korro is based in Cambridge, Massachusetts. </span></div><div><br></div><div><span style="font-size: 11pt">We are collaborative and united by a common mission. We are building a company with extraordinary people with an audacious vision to create transformative genetic medicines for prevalent diseases. Our values - </span><i style="font-size: 11pt">Rewrite the future, On the Cutting Edge, Better Together, Dynamically Different, Kindness and Integrity </i><span style="font-size: 11pt">form the fabric of the organization. They are reinforced daily and serve as key dimensions in the hiring process to help us ensure that Korro is a magnet for outstanding talent and a great place to work. Join us as we redefine what's possible in genetic medicine and work to make a lasting impact on human health.</span></div><div><br></div><div><b style="font-size: 11pt;">Position Summary:</b><span style="font-size: 11pt;">&nbsp;​Korro Bio is&nbsp;seeking&nbsp;a highly motivated&nbsp;Associate&nbsp;Scientist&nbsp;to join our&nbsp;HTS-NGS operations team&nbsp;and work with an enthusiastic team of highly skilled scientists. The ideal candidate&nbsp;for this lab-based position&nbsp;is committed to&nbsp;delivering&nbsp;high quality results&nbsp;in a timely manner.&nbsp;This is an exciting opportunity to be part of a&nbsp;collaborative&nbsp;team and contribute to the development of next-generation RNA editing technology and therapeutics in a fast-paced biotech company.​</span><span style="font-size: 10.5pt;">&nbsp;</span></div>

Associate Scientist, HTS & NGS

<div><b>Company Summary:</b>&nbsp;<span style="font-size: 11pt">Korro is a biopharmaceutical company focused on developing a new class of genetic medicines for both rare and highly prevalent diseases using its proprietary RNA editing platform. Korro is generating a portfolio of differentiated programs that are designed to harness the body’s natural RNA editing process to effect a precise yet transient single base edit. By editing RNA instead of DNA, Korro is expanding the reach of genetic medicines by delivering additional precision and tunability, which has the potential for increased specificity and improved long-term tolerability. Using an oligonucleotide-based approach, Korro expects to bring its medicines to patients by leveraging its proprietary platform with precedented delivery modalities, manufacturing know-how, and established regulatory pathways of approved oligonucleotide drugs. Korro is based in Cambridge, Massachusetts. </span></div><div><br></div><div><span style="font-size: 11pt">We are collaborative and united by a common mission. We are building a company with extraordinary people with an audacious vision to create transformative genetic medicines for prevalent diseases. Our values - </span><i style="font-size: 11pt">Rewrite the future, On the Cutting Edge, Better Together, Dynamically Different, Kindness and Integrity </i><span style="font-size: 11pt">form the fabric of the organization. They are reinforced daily and serve as key dimensions in the hiring process to help us ensure that Korro is a magnet for outstanding talent and a great place to work. Join us as we redefine what's possible in genetic medicine and work to make a lasting impact on human health.</span></div><div><br></div><div><span style="font-size: 10pt;"><b>Position Summary:&nbsp;&nbsp;</b></span></div><div><span style="font-size: 10pt;">The successful candidate will have a strong background leading early phase clinical trials. This individual will use outstanding cross-functional skills to achieve study and program goals and will develop a solid understanding of the clinical indications being pursued including knowledge of the patient needs, development plan, applicable regulatory guidance as well as the competitive landscape in the therapeutic space.</span></div>

Senior Manager, Clinical Operations

<div><b>Company Summary:</b>&nbsp;<span style="font-size: 11pt">Korro is a biopharmaceutical company focused on developing a new class of genetic medicines for both rare and highly prevalent diseases using its proprietary RNA editing platform. Korro is generating a portfolio of differentiated programs that are designed to harness the body’s natural RNA editing process to effect a precise yet transient single base edit. By editing RNA instead of DNA, Korro is expanding the reach of genetic medicines by delivering additional precision and tunability, which has the potential for increased specificity and improved long-term tolerability. Using an oligonucleotide-based approach, Korro expects to bring its medicines to patients by leveraging its proprietary platform with precedented delivery modalities, manufacturing know-how, and established regulatory pathways of approved oligonucleotide drugs. Korro’s lead program is Alpha-1 Antitrypsin Deficiency (AATD). Korro is based in Cambridge, Massachusetts. </span></div><div><br></div><div><span style="font-size: 11pt">We are collaborative and united by a common mission. We are building a company with extraordinary people with an audacious vision to create transformative genetic medicines for prevalent diseases. Our values - </span><i style="font-size: 11pt">Rewrite the future, On the Cutting Edge, Better Together, Dynamically Different, Kindness and Integrity </i><span style="font-size: 11pt">form the fabric of the organization. They are reinforced daily and serve as key dimensions in the hiring process to help us ensure that Korro is a magnet for outstanding talent and a great place to work. Join us as we redefine what's possible in genetic medicine and work to make a lasting impact on human health.</span></div><div><br></div><div><b>Position Summary:</b></div><div>The Senior Director/Vice President of Regulatory Affairs will serve as the strategic and operational leader responsible for developing and executing global regulatory strategies to support clinical development, registration, and commercialization of the company’s pipeline. This individual will provide leadership and direction to internal teams and external partners, ensuring regulatory compliance and fostering effective interactions with global health authorities. Reporting to the Chief Scientific Officer, this position will work in close partnership with the VP of Clinical Operations, VP of Clinical Development and VP Research &amp; Preclinical to ensure seamless execution of Korro's preclinical and clinical regulatory strategy.</div>

Senior Director/Vice President, Regulatory Affairs

<div><b>Company Summary:</b>&nbsp;<span style="font-size: 11pt">Korro is a biopharmaceutical company focused on developing a new class of genetic medicines for both rare and highly prevalent diseases using its proprietary RNA editing platform. Korro is generating a portfolio of differentiated programs that are designed to harness the body’s natural RNA editing process to effect a precise yet transient single base edit. By editing RNA instead of DNA, Korro is expanding the reach of genetic medicines by delivering additional precision and tunability, which has the potential for increased specificity and improved long-term tolerability. Using an oligonucleotide-based approach, Korro expects to bring its medicines to patients by leveraging its proprietary platform with precedented delivery modalities, manufacturing know-how, and established regulatory pathways of approved oligonucleotide drugs. Korro is based in Cambridge, Massachusetts. </span></div><div><br></div><div><span style="font-size: 11pt">We are collaborative and united by a common mission. We are building a company with extraordinary people with an audacious vision to create transformative genetic medicines for prevalent diseases. Our values - </span><i style="font-size: 11pt">Rewrite the future, On the Cutting Edge, Better Together, Dynamically Different, Kindness and Integrity </i><span style="font-size: 11pt">form the fabric of the organization. They are reinforced daily and serve as key dimensions in the hiring process to help us ensure that Korro is a magnet for outstanding talent and a great place to work. Join us as we redefine what's possible in genetic medicine and work to make a lasting impact on human health.</span></div><div><br></div><div><span style="font-size: 10pt;">Reporting to the Vice President, Clinical Development Operations, the Director, Clinical Data Management supports the Clinical Development organization by providing expertise in all aspects of clinical data management for assigned study(ies). The person in this role will participate with both strategic and hands-on support, oversight of vendors/CROs, and contributions to departmental process and standards development</span></div><div><span style="font-size: 10pt;">&nbsp;</span></div><div><span style="font-size: 10pt;">Excellent written and oral communication skills are required, as is the desire and ability to work in a small, fast-paced, and patient-focused environment.</span></div>

Director, Clinical Data Management

<div><b>Company Summary:</b>&nbsp;<span style="font-size: 11pt">Korro is a biopharmaceutical company focused on developing a new class of genetic medicines for both rare and highly prevalent diseases using its proprietary RNA editing platform. Korro is generating a portfolio of differentiated programs that are designed to harness the body’s natural RNA editing process to effect a precise yet transient single base edit. By editing RNA instead of DNA, Korro is expanding the reach of genetic medicines by delivering additional precision and tunability, which has the potential for increased specificity and improved long-term tolerability. Using an oligonucleotide-based approach, Korro expects to bring its medicines to patients by leveraging its proprietary platform with precedented delivery modalities, manufacturing know-how, and established regulatory pathways of approved oligonucleotide drugs. Korro is based in Cambridge, Massachusetts. </span></div><div><br></div><div><span style="font-size: 11pt">We are collaborative and united by a common mission. We are building a company with extraordinary people with an audacious vision to create transformative genetic medicines for prevalent diseases. Our values - </span><i style="font-size: 11pt">Rewrite the future, On the Cutting Edge, Better Together, Dynamically Different, Kindness and Integrity </i><span style="font-size: 11pt">form the fabric of the organization. They are reinforced daily and serve as key dimensions in the hiring process to help us ensure that Korro is a magnet for outstanding talent and a great place to work. Join us as we redefine what's possible in genetic medicine and work to make a lasting impact on human health.</span></div><div><br></div><div> <p>The Associate Director, Supply Chain Management will lead the strategic and operational management of complex clinical supply activities across all phases of development to provide life-changing therapeutics for patients. The position ensures the uninterrupted, compliant, and cost-effective delivery of investigational products to global clinical trial sites. The ideal candidate will bring deep expertise in supply chain strategy, vendor oversight, and cross-functional collaboration, with a strong understanding of GMP, IRT systems, and regulatory requirements.</p> <p>Excellent written and oral communication skills are required, as is the desire and ability to work in a small, fast-paced, and patient-focused environment.</p> </div>

Associate Director, Supply Chain Management

<div><b>Company Summary:</b>&nbsp;<span style="font-size: 11pt">Korro is a biopharmaceutical company focused on developing a new class of genetic medicines for both rare and highly prevalent diseases using its proprietary RNA editing platform. Korro is generating a portfolio of differentiated programs that are designed to harness the body’s natural RNA editing process to effect a precise yet transient single base edit. By editing RNA instead of DNA, Korro is expanding the reach of genetic medicines by delivering additional precision and tunability, which has the potential for increased specificity and improved long-term tolerability. Using an oligonucleotide-based approach, Korro expects to bring its medicines to patients by leveraging its proprietary platform with precedented delivery modalities, manufacturing know-how, and established regulatory pathways of approved oligonucleotide drugs. Korro is based in Cambridge, Massachusetts. </span></div><div><br></div><div><span style="font-size: 11pt">We are collaborative and united by a common mission. We are building a company with extraordinary people with an audacious vision to create transformative genetic medicines for prevalent diseases. Our values - </span><i style="font-size: 11pt">Rewrite the future, On the Cutting Edge, Better Together, Dynamically Different, Kindness and Integrity </i><span style="font-size: 11pt">form the fabric of the organization. They are reinforced daily and serve as key dimensions in the hiring process to help us ensure that Korro is a magnet for outstanding talent and a great place to work. Join us as we redefine what's possible in genetic medicine and work to make a lasting impact on human health.</span></div><div><br></div><div> <p>Korro Bio is seeking a passionate, driven, and creative Associate Scientist to join our oligonucleotide compound management team and work with an enthusiastic team of highly skilled scientists in a dynamic, growing company. The successful candidate will be responsible for handling, characterization, automation, storage and distribution of oligonucleotide compounds and work closely with cross functional team to advance our RNA editing drug discovery programs. The candidate will also be responsible for quantifying, performing purity analysis via HPLC/LCMS, and documenting results. The candidate will prepare samples and distribution of information to the downstream assay teams and pipelines. Additional responsibilities include cell screening and NGS work. Candidate must express a high attention to detail, be comfortable multitasking, oversee day to day operations and ability to function in an interdisciplinary and fast-paced startup environment.</p> </div>

Associate Scientist, Compound Management, Cell Screening & NGS

<div><b>Company Summary:</b>&nbsp;<span style="font-size: 11pt">Korro is a biopharmaceutical company focused on developing a new class of genetic medicines for both rare and highly prevalent diseases using its proprietary RNA editing platform. Korro is generating a portfolio of differentiated programs that are designed to harness the body’s natural RNA editing process to effect a precise yet transient single base edit. By editing RNA instead of DNA, Korro is expanding the reach of genetic medicines by delivering additional precision and tunability, which has the potential for increased specificity and improved long-term tolerability. Using an oligonucleotide-based approach, Korro expects to bring its medicines to patients by leveraging its proprietary platform with precedented delivery modalities, manufacturing know-how, and established regulatory pathways of approved oligonucleotide drugs. Korro is based in Cambridge, Massachusetts. </span></div><div><br></div><div><span style="font-size: 11pt">We are collaborative and united by a common mission. We are building a company with extraordinary people with an audacious vision to create transformative genetic medicines for prevalent diseases. Our values - </span><i style="font-size: 11pt">Rewrite the future, On the Cutting Edge, Better Together, Dynamically Different, Kindness and Integrity </i><span style="font-size: 11pt">form the fabric of the organization. They are reinforced daily and serve as key dimensions in the hiring process to help us ensure that Korro is a magnet for outstanding talent and a great place to work. Join us as we redefine what's possible in genetic medicine and work to make a lasting impact on human health.</span></div>

Senior Scientist, Computational Biology

<div><b>Company Summary:</b>&nbsp;<span style="font-size: 11pt">Korro is a biopharmaceutical company focused on developing a new class of genetic medicines for both rare and highly prevalent diseases using its proprietary RNA editing platform. Korro is generating a portfolio of differentiated programs that are designed to harness the body’s natural RNA editing process to effect a precise yet transient single base edit. By editing RNA instead of DNA, Korro is expanding the reach of genetic medicines by delivering additional precision and tunability, which has the potential for increased specificity and improved long-term tolerability. Using an oligonucleotide-based approach, Korro expects to bring its medicines to patients by leveraging its proprietary platform with precedented delivery modalities, manufacturing know-how, and established regulatory pathways of approved oligonucleotide drugs. Korro is based in Cambridge, Massachusetts. </span></div><div><br></div><div><span style="font-size: 11pt">We are collaborative and united by a common mission. We are building a company with extraordinary people with an audacious vision to create transformative genetic medicines for prevalent diseases. Our values - </span><i style="font-size: 11pt">Rewrite the future, On the Cutting Edge, Better Together, Dynamically Different, Kindness and Integrity </i><span style="font-size: 11pt">form the fabric of the organization. They are reinforced daily and serve as key dimensions in the hiring process to help us ensure that Korro is a magnet for outstanding talent and a great place to work. Join us as we redefine what's possible in genetic medicine and work to make a lasting impact on human health.</span></div><div><br></div><div>Korro Bio is seeking a highly motivated Associate Director or Director of Toxicology to lead the design and execution of nonclinical safety studies across our RNA editing portfolio. Reporting to the Senior Director, DMPK, this individual will be a key scientific and strategic contributor responsible for building and advancing Korro’s toxicology capabilities, with an emphasis on oligonucleotide-based therapeutics. The ideal candidate brings deep experience in nonclinical development, a collaborative mindset, and a passion for bringing novel genetic medicines to patients.</div>

Associate Director / Director, Toxicology

<div><b>Company Summary:</b>&nbsp;<span style="font-size: 11pt">Korro is a biopharmaceutical company focused on developing a new class of genetic medicines for both rare and highly prevalent diseases using its proprietary RNA editing platform. Korro is generating a portfolio of differentiated programs that are designed to harness the body’s natural RNA editing process to effect a precise yet transient single base edit. By editing RNA instead of DNA, Korro is expanding the reach of genetic medicines by delivering additional precision and tunability, which has the potential for increased specificity and improved long-term tolerability. Using an oligonucleotide-based approach, Korro expects to bring its medicines to patients by leveraging its proprietary platform with precedented delivery modalities, manufacturing know-how, and established regulatory pathways of approved oligonucleotide drugs. Korro is based in Cambridge, Massachusetts. </span></div><div><br></div><div><span style="font-size: 11pt">We are collaborative and united by a common mission. We are building a company with extraordinary people with an audacious vision to create transformative genetic medicines for prevalent diseases. Our values - </span><i style="font-size: 11pt">Rewrite the future, On the Cutting Edge, Better Together, Dynamically Different, Kindness and Integrity </i><span style="font-size: 11pt">form the fabric of the organization. They are reinforced daily and serve as key dimensions in the hiring process to help us ensure that Korro is a magnet for outstanding talent and a great place to work. Join us as we redefine what's possible in genetic medicine and work to make a lasting impact on human health.</span></div><div><br></div><div>Korro Bio is seeking a highly motivated Research Associate to join our In Vivo Pharmacology team. This is an exceptional opportunity to work alongside experienced scientists in a collaborative, cross-functional environment as we advance transformative genetic medicines to improve the lives of patients.</div>

Research Associate, In Vivo Pharmacology

Director, CMC QA

Associate Director, Clinical Supply Chain Management

<div><b>Company Summary:</b>&nbsp;<span style="font-size: 11pt">Korro is a biopharmaceutical company focused on developing a new class of genetic medicines for both rare and highly prevalent diseases using its proprietary RNA editing platform. Korro is generating a portfolio of differentiated programs that are designed to harness the body’s natural RNA editing process to effect a precise yet transient single base edit. By editing RNA instead of DNA, Korro is expanding the reach of genetic medicines by delivering additional precision and tunability, which has the potential for increased specificity and improved long-term tolerability. Using an oligonucleotide-based approach, Korro expects to bring its medicines to patients by leveraging its proprietary platform with precedented delivery modalities, manufacturing know-how, and established regulatory pathways of approved oligonucleotide drugs. Korro is based in Cambridge, Massachusetts. </span></div><div><br></div><div><span style="font-size: 11pt">We are collaborative and united by a common mission. We are building a company with extraordinary people with an audacious vision to create transformative genetic medicines for prevalent diseases. Our values - </span><i style="font-size: 11pt">Rewrite the future, On the Cutting Edge, Better Together, Dynamically Different, Kindness and Integrity </i><span style="font-size: 11pt">form the fabric of the organization. They are reinforced daily and serve as key dimensions in the hiring process to help us ensure that Korro is a magnet for outstanding talent and a great place to work. Join us as we redefine what's possible in genetic medicine and work to make a lasting impact on human health.</span></div><div><br></div><div> <p>Korro Bio&nbsp;is&nbsp;seeking an experienced analytical scientist to join the growing CMC team. You will focus on management of CMO analytical labs as well as development of analytical methods, characterization of impurities, degradation pathways, and transfer, qualification/validation of analytical methods for synthetic oligonucleotide-based therapies. This role will support and manage - the quality and stability of drug substances and drug products throughout the development lifecycle. You will work closely with cross-functional teams and external partners to ensure that analytical data supports regulatory filings and clinical trial progression.</p> </div>

RNA Therapeutics Scientist

Your career is worth investing in.

Get unlimited referrals with Premium.